as mentioned in upi
Schizophrenia drug slows pancreatic cancer growth in mice
Schizophrenia drug slows pancreatic cancer growth in mice
WASHINGTON, Sept. 7 (UPI) -- Pancreatic cancer often does not cause symptoms, so it is diagnosed late, metastasizes earlier than other cancer and rapidly becomes resistant to chemotherapy, making it one of the most difficult types of the disease to treat.Researchers have found schizophrenia drugs were effective at slowing the growth of pancreatic tumors and impeding their ability to prolifierate, according to a study published in the journal Gastroenterology.Pancreatic cancer accounts for about 3 percent of cancer cases in the United States, but 7 percent of cancer deaths, according to the American Cancer Society.The organization says that this year, about 53,070 people are expected to be diagnosed with the disease, and roughly 41,780 will die of it.
furthermore sciencealert
The US has given fast-track approval to a surprising new cancer drug
The US has given fast-track approval to a surprising new cancer drug
A new cancer drug called Venetoclax is causing quite a stir in the medical community, with the announcement that the US FDA has given it fast-track approval for the treatment of patients with chronic lymphocytic leukemia (CLL).CLL is one of the most common types of leukemia in adults, and during a recent clinical trial, 80 percent of patients treated with Venetoclax experienced complete or partial remission of their cancer.Developed in Australia over several decades, Venetoclax is taken in pill-form, and of the small sample of patients who have been treated with it so far, some reported no adverse side-effects at all."It causes no side-effects.
additionally news-medical
Experimental drug shows promise for stopping melanoma and other forms of cancer
Experimental drug shows promise for stopping melanoma and other forms of cancer
An experimental cancer drug works differently than intended and shows significant promise for stopping melanoma and possibly other forms of cancer, research from the University of Virginia School of Medicine suggests.The findings also indicate the drug may be effective against melanomas that have resisted other forms of treatment.The drug, pevonedistat, is already being tested in people.Scientists have been uncertain exactly how it kills cancer cells, as it shuts down many different cellular proteins - hundreds if not thousands.
No comments:
Post a Comment